ACTIVE

APOTHEEK DE GAPER

Financial year 2025 · Closed on 31/12/2025

Net result52,7 k €-9,9 %over 1 year
Gross margin157,4 k €-15,7 %over 1 year
Equity129,1 k €+68,9 %over 1 year
Workforce1,2 ETP-14,3 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK DE GAPER is a Public limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Mortsel. It employs on average 1,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0439.125.433
Incorporation
13/12/1989
Legal form
Public limited company
Registered office
Liersesteenweg 77
2640 Mortsel · FlandreSee on map
Contributed capital
83 044,33 €
Latest accounts
31/12/2025
Average workforce
1,2 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 13 financial years

20252024202320222021
Income statement
Gross margin157,4 k €186,6 k €132,7 k €193,7 k €151,3 k €
EBITDA67,4 k €101,7 k €40,1 k €85,3 k €56,4 k €
Operating result61,8 k €67,6 k €5,7 k €51,1 k €23 k €
Net result52,7 k €58,4 k €-5,5 k €39,6 k €11,5 k €
Balance sheet
Equity129,1 k €76,4 k €18 k €23,4 k €-16,2 k €
Total assets228,1 k €223,3 k €260,3 k €268,9 k €310,7 k €
Cash31,4 k €19,2 k €41,6 k €35,1 k €31,7 k €
Debts99 k €146,9 k €242,4 k €245,4 k €326,9 k €
Other
Workforce1,2 ETP1,4 ETP1,4 ETP1,7 ETP1,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 25 ended

Active mandates

FARMALEX

Gedelegeerd bestuurder · since 31 mars 2011 · 0464.917.139

Represented by Peter Verbiest

Active
Martine Desmet

Bestuurder · since 31 mars 2011

Active
Peter Verbiest

Bestuurder · since 31 mars 2011

Active

Ended mandates

Bert Van den Broeck

Director · since 31 mars 2011 · until 31 mars 2017

Ended
FARMAFLEX

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0430.701.675

Represented by Peter Verbiest

Ended
FARMALEX

Gedelegeerd bestuurder · since 31 mars 2011 · 0464.917.139

Represented by Peter Verbiest

Ended
FARMALEX

Managing director · since 31 mars 2011 · until 31 mars 2023 · 0464.917.139

Represented by Peter Verbiest

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/07/202604/06/202505/06/202401/06/202320/07/202229/07/2021
General meeting31/05/202631/05/202531/05/202431/05/202331/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202531/05/202630/07/2026DutchPDF
Abridged model31/12/202431/05/202504/06/2025DutchPDF
Abridged model31/12/202331/05/202405/06/2024DutchPDF
Abridged model31/12/202231/05/202301/06/2023DutchPDF
Abridged model31/12/202131/05/202220/07/2022DutchPDF
Abridged model31/12/202031/05/202129/07/2021DutchPDF
Abridged model31/12/201931/05/202014/07/2020DutchPDF
Abridged model31/12/201831/05/201916/07/2019DutchPDF
Abridged model31/12/201731/05/201827/07/2018DutchPDF
Abridged model31/12/201631/05/201726/07/2017DutchPDF
Abridged model31/12/201531/05/201625/08/2016DutchPDF
Abridged model31/12/201431/05/201524/08/2015DutchPDF
Abridged model31/12/201326/05/201427/08/2014DutchPDF
Abridged model31/12/201227/05/201306/08/2013DutchPDF
Abridged model31/12/201129/05/201229/08/2012DutchPDF
Abridged model31/12/201031/05/201110/08/2011DutchPDF
Abridged model31/12/200931/05/201012/08/2010DutchPDF
Abridged model31/12/200825/05/200924/07/2009DutchPDF
Abridged model31/12/200726/05/200829/07/2008DutchPDF
Abridged model31/12/200628/05/200707/08/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 25 ended

Active mandates

FARMALEX

Gedelegeerd bestuurder · since 31 mars 2011 · 0464.917.139

Represented by Peter Verbiest

Active
Martine Desmet

Bestuurder · since 31 mars 2011

Active
Peter Verbiest

Bestuurder · since 31 mars 2011

Active

Ended mandates

Bert Van den Broeck

Director · since 31 mars 2011 · until 31 mars 2017

Ended
FARMAFLEX

Managing director · since 31 mars 2011 · until 31 mars 2017 · 0430.701.675

Represented by Peter Verbiest

Ended
FARMALEX

Gedelegeerd bestuurder · since 31 mars 2011 · 0464.917.139

Represented by Peter Verbiest

Ended
FARMALEX

Managing director · since 31 mars 2011 · until 31 mars 2023 · 0464.917.139

Represented by Peter Verbiest

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/06/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares06/02/2012
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates27/09/2006
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202552,7 k €↓
  2. 2024
    Annual accounts 202458,4 k €↑
  3. 2023
    Annual accounts 2023-5,5 k €↓
  4. 2022
    Annual accounts 202239,6 k €↑
  5. 2021
    Annual accounts 202111,5 k €↑
  6. 2013
    Annual accounts 20133,7 k €↑
  7. 2012
    Annual accounts 2012-4,6 k €↑
  8. 2011
    Annual accounts 2011-10,1 k €↓
  9. 2010
    Annual accounts 20109,9 k €↓
  10. 2009
    Annual accounts 200922,9 k €↓
  11. 2008
    Annual accounts 200824,2 k €↓
  12. 2007
    Annual accounts 200725 k €↑
  13. 2006
    Annual accounts 200624,1 k €
  14. 13/12/1989
    IncorporationPublic limited company